Cover Image
市場調查報告書

止血、組織密封膠的全球市場 2014-2020年 - 局部止血用產品 (機械性止血材料、活性和流體止血劑)、連接、組織密閉用產品 (天然組織密封膠、合成天然組織密封膠、防沾黏貼片)

Hemostasis and Tissue Sealing Agents Market (Topical Hemostats and Tissue Sealing Agents) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

出版商 Transparency Market Research 商品編碼 326020
出版日期 內容資訊 英文 85 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
止血、組織密封膠的全球市場 2014-2020年 - 局部止血用產品 (機械性止血材料、活性和流體止血劑)、連接、組織密閉用產品 (天然組織密封膠、合成天然組織密封膠、防沾黏貼片) Hemostasis and Tissue Sealing Agents Market (Topical Hemostats and Tissue Sealing Agents) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
出版日期: 2015年01月27日 內容資訊: 英文 85 Pages
簡介

止血、組織密封膠市場,是從出血控制方面支援外科手術的止血、組織密閉、防沾黏貼片的需要廣泛研究的領域。在手術中損傷血管的血流管理中這些商品擔負不可缺少的角色,近幾年的先進技術開發對其進步與成本效果有所貢獻。

本報告以止血、組織密封膠的全球市場為焦點,提供考察現狀與今後潛力所需的,全球整體及各地區的交易規模的變化檢驗與預測、市場推動與阻礙因素、發展機會、產業價值鏈、競爭環境、市場向心力等的相關分析資訊、主要加入企業簡介彙整。

第1章 序

第2章 摘要整理

  • 市場簡述:止血、組織密封膠的全球市場
  • 止血、組織密封膠的全球市場 - 各形式 (單位:100萬美元)
    • 比較分析:組織密封膠的全球市場 - 各地區 (金額成長率)

第3章 市場概要

  • 概要
  • 市場動態
    • 市場推動要素
      • 新產品開發伴隨的技術提高
      • 高漲的微創手術意願
      • 人口高齡化增加而需要止血產品的手術
        • 全球年齡結構變化
    • 阻礙市場要素
      • 高額的成本與嚴厲的法規必要條件
      • 併發症風險
    • 機會
      • 新興國家投資提供企業高收益化的良好基礎
      • 堅實的研究開發
  • 波特的五力分析:止血、組織密封膠的全球市場
  • 市場向心力分析:止血、組織密封膠的全球市場 - 各地區
  • 止血、組織密封膠主要企業的全球市場佔有率競爭環境 (金額構成比)
    • 止血、組織密封膠的全球市場佔有率分析 - 各主要企業 (金額構成比)

第4章 止血、組織密封膠的全球市場 - 各產品形式

  • 概要
    • 全球市場收入 - 各產品形式 (單位:100萬美元)
  • 局部止血用產品
    • 全球市場收入 - 各形式 (單位:100萬美元)
    • 機器的止血材料
    • 活性止血劑
    • 流體止血劑
  • 連接、組織密閉用產品
    • 全球市場收入 - 各形式 (單位:100萬美元)
    • 天然組織密封膠
    • 合成天然組織密封膠
    • 防止粘連產品

第5章 止血、組織密封膠的全球市場 - 各地區

  • 概要
    • 全球市場收入 - 各地區 (單位:100萬美元)
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第6章 建議

  • 引進多用途且馬上可使用的產品
  • 著重行銷宣傳活動
  • 對研究開發的積極配合措施

第7章 企業簡介 (企業概要、財務概況、產品系列、產業策略、最新發展)

  • Advanced Medical Solutions Group plc
  • Baxter
  • Cohera Medical, Inc.
  • CryoLife, Inc.
  • C.R. Bard, Inc.
  • Johnson & Johnson Services, Inc.
  • Integra LifeSciences Corporation
  • Pfizer, Inc.
目錄

The hemostasis and tissue sealing agents market involves the study of wide range of hemostat, tissue sealant and adhesion barrier products which helps the surgeons to control bleeding during the surgery. These products play an important role in management of bleeding within the damaged blood vessels in surgical procedures. The market of hemostasis and tissue sealing agents is witnessing positive growth due to the introduction of technology advanced and cost effective hemostat and tissue sealing products by key companies. For example, in June 2013, Advance Medical Solution Group plc received approval for 2-octyl cyanoacrylate synthetic tissue adhesive.

The company also offers wide range of hemostasis and tissue sealant products such as RESORBA, ActivHeal and LiquiBand. Thus, wide range of product offering will boost the uptake of these products hence drive the market growth. Other factors such as aging population and rising number surgical procedures further drive the growth of the hemostasis and tissue sealing agents market globally. For example, according to the World Health Organization (WHO), the number of people aged 65 years and above is expected to increase from 605 million to 2 billion by 2050. Aging population will boost the number of people undergoing surgical intervention which would in turn stimulate the demand of hemostat and tissue sealing agents. In addition, hemostat and tissue sealant products are still at a nascent stage in developing regions such as India and Latin America and expected to witness high growth rate in near future owing to the approval of new hemostat products by regulatory authorities. All these factors collectively fuel the revenues of hemostasis and tissue sealing agents market during the study period, hence boost market growth. However, strict regulatory policies coupled with high cost of the products will restrain the market growth worldwide.

This report encompasses a detailed study of various hemostat and tissue sealing agents. Hemostasis and tissue sealing agents market have been majorly segmented into types of products. This segment is categorized into two major type namely topical hemostats and adhesive and tissue sealant products. Topical hemostat products are further categorized into mechanical hemostat, active hemostat (i.e. thrombin based topical hemostat) and flowable hemostat (i.e. combinational topical hemostat). Hemostat products such as collagen, oxidized regenerated cellulose (ORC), gelatin and polysaccharide based topical hemostat are included under mechanical hemostat.

Adhesive and tissue sealant are classified into natural tissue sealant, synthetic tissue sealant and adhesion barrier products. Natural tissue sealant comprises fibrin sealant and others (albumin and collagen based tissue sealant). Synthetic sealant includes cyanoacrylate based tissue sealant and others (polyethylene glycol and others). The market size and forecast for each type of products has been provided for the period 2012 to 2020, considering 2013 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2014 to 2020 for each segment.

Geographically, the global hemostasis and tissue sealing agents market has been segmented into four major regions namely North America, Europe, Asia Pacific and Rest of the World (RoW). The market size and forecast for each geography has been estimated for the period 2012 to 2020 in terms of revenue (USD million), considering 2013 as the base year. The report also provides the compounded annual growth rate (CAGR %) during the forecast period from 2014 to 2020 for all the geographies mentioned above.

The market overview section of the report discusses the market dynamics with respect to the market drivers, restraints and opportunities. This section also covers market attractiveness analysis and event impact analysis of the global hemostasis and tissue sealing agents market. Market share (%) of major players operating in the market has also been provided for the year 2013, followed by a list of recommendations for existing and new players to enter and enhance market share. The report concludes with company profiles of key players operating in various segments of the market. Each company profile includes business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Some of the prominent players in the global hemostasis and tissue sealing agents market that have been profiled in the report include Johnson & Johnson Services, Inc., CryoLife, Inc., Baxter, Cohesion Technologies, C.R. Bard, Inc., Advance Medical Solution Group plc, Integra LifeScience, Pfizer, Inc. and others.

The Global Hemostasis and Tissue Sealing Agents market is segmented as follows:

Global Hemostasis and Tissue Sealing Agents Market, by Types of Products

  • Topical Hemostats
    • Mechanical Hemostats
    • Collagen based Topical Hemostats
    • Oxidized Regenerated Cellulose (ORC) based Topical Hemostats
    • Gelatin based Topical Hemostats
    • Polysaccharide based Topical Hemostat
    • Active Hemostats (Thrombin-Based Topical Hemostats)
    • Flowable Hemostats (Combination Topical Hemostats)
  • Adhesive and Tissue Sealing Agents
    • Natural Tissue Sealant
    • Fibrin Sealant
    • Other Natural Sealant (Albumin and Collagen based Tissue Sealant)
    • Synthetic Tissue Sealant
    • Cynoacrylate-Based Tissue Adhesives
    • Other Synthetic Tissue Sealant (Polyethylene Glycol and others)
    • Adhesion Barrier Products

Global Hemostasis and Tissue Sealing Agents Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 Preface

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology
    • 1.3.1 Sources
      • 1.3.1.1 Secondary Research
      • 1.3.1.2 Primary Research
      • 1.3.1.3 Assumption

Chapter 2 Executive Summary

  • 2.1 Market Snapshot: Global Hemostasis and Tissue Sealing Agents Market (2013 & 2020)
  • 2.2 Global Hemostasis and Tissue Sealing Agents Market, by Types of Products, 2013 (USD Million)
    • 2.2.1 Comparative Analysis: Global Hemostasis and Tissue Sealing Agents Market, by Geography, 2013 and 2020 (Value %)

Chapter 3 Market Overview

  • 3.1 Overview
  • 3.2 Market Dynamics
    • 3.2.1 Market Drivers
      • 3.2.1.1 Technology improvements coupled with new product development
      • 3.2.1.2 Rising trend of minimally invasive procedures
      • 3.2.1.3 Aging population increases the number of surgeries needing hemostat products
        • 3.2.1.3.1 Global Percentage Change in the World's Population by Age: 2010-2050
    • 3.2.2 Market Restraints
      • 3.2.2.1 High cost and strict regulatory requirement
      • 3.2.2.2 Risk of complications
    • 3.2.3 Opportunities
      • 3.2.3.1 Investing in emerging economies provides a good platform for companies to record high revenue
        • 3.2.3.1.1 Latin America Aging Population % Change as Compared to the total Latin American Population Age: 2005 - 2050
      • 3.2.3.2 Strong research and development
  • 3.3 Porter's Five Forces Analysis: Global Hemostasis and Tissue Sealing Agents Market
    • 3.3.1 Bargaining power of suppliers
    • 3.3.2 Bargaining power of buyers
    • 3.3.3 Threat of substitutes
    • 3.3.4 Threat of new entrants
    • 3.3.5 Competitive rivalry
  • 3.4 Market Attractiveness Analysis: Global Hemostasis and Tissue Sealing Agents Market, by Geography
  • 3.5 Market Share by Key Players of Global Hemostasis and Tissue Sealing Agents Market, 2013 (%)
    • 3.5.1 Global Hemostasis and Tissue Sealing Agents Market Share Analysis, by Key Players, 2013 (%)

Chapter 4 Global Hemostasis and Tissue Sealing Agents Market, by Types of Products

  • 4.1 Overview
    • 4.1.1 Global Hemostasis and Tissue Sealing Agents Market Revenue, by Types of Products, 2012 - 2020 (USD Million)
  • 4.2 Topical Hemostats
    • 4.2.1 Global Topical Hemostats Market Revenue, by Types, 2012 - 2020 (USD Million)
    • 4.2.2 Mechanical Hemostats
      • 4.2.2.1 Global Mechanical Hemostats Market Revenue, by Types, 2012 - 2020 (USD Million)
      • 4.2.2.2 Collagen-based Hemostats
        • 4.2.2.2.1 Global Collagen-based Hemostats Market Revenue, 2012 - 2020, (USD Million)
      • 4.2.2.3 Oxidized Regenerated Cellulose-based (ORC) Hemostats
        • 4.2.2.3.1 Global ORC-based Topical Hemostats Market Revenue, 2012 - 2020, (USD Million)
      • 4.2.2.4 Gelatin-based Hemostats
        • 4.2.2.4.1 Global Gelatin-based Hemostats Market Revenue, 2012 - 2020, (USD Million)
      • 4.2.2.5 Polysaccharide-based Hemostats
        • 4.2.2.5.1 Global Polysaccharide-based Hemostats Market Revenue, 2012 - 2020, (USD Million)
    • 4.2.3 Active Hemostats (Thrombin-based Topical Hemostats)
      • 4.2.3.1 Global Active Hemostats Market Revenue, 2012 - 2020, (USD Million)
    • 4.2.4 Flowable Hemostats (Combination Topical Hemostats)
      • 4.2.4.1 Global Flowable Hemostats Market Revenue, 2012 - 2020, (USD Million)
  • 4.3 Adhesive and Tissue Sealing Agents
    • 4.3.1 Global Adhesive and Tissue Sealing Agents Market Revenue, by Types, 2012 - 2020 (USD Million)
    • 4.3.2 Natural Tissue Sealant
      • 4.3.2.1 Global Natural Tissue Sealants Market Revenue, by Types, 2012 - 2020 (USD Million)
      • 4.3.2.2 Fibrin-based Tissue Sealant
        • 4.3.2.2.1 Global Fibrin-based Tissue Sealant Market Revenue, 2012 - 2020, (USD Million)
      • 4.3.2.3 Other Natural Tissue Sealant (Albumin and Collagen based tissue Sealant)
        • 4.3.2.3.1 Global Other Natural Tissue Sealant Market Revenue, 2012 - 2020, (USD Million)
    • 4.3.3 Synthetic Tissue Sealant
      • 4.3.3.1 Global Synthetic Tissue Sealant Market Revenue, by Types, 2012 - 2020 (USD Million)
      • 4.3.3.2 Cyanoacrylate-based Tissue Sealant
        • 4.3.3.2.1 Global Cyanoacrylate-based Tissue Sealant Market Revenue, 2012 - 2020, (USD Million)
      • 4.3.3.3 Other Synthetic Tissue Sealant (Polyethylene Glycol and others)
        • 4.3.3.3.1 Global Other Synthetic Tissue Sealant Market Revenue, 2012 - 2020, (USD Million)
    • 4.3.4 Adhesion Barrier Products
      • 4.3.4.1 Global Adhesion Barrier Products Market Revenue, 2012 - 2020, (USD Million)

Chapter 5 Global Hemostasis and Tissue Sealing Agents Market, by Geography

  • 5.1 Overview
    • 5.1.1 Global Hemostasis and Tissue Sealing Agents Market Revenue, by Geography, 2012 - 2020 (USD Million)
  • 5.2 North America
    • 5.2.1 North America Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020, (USD Million)
  • 5.3 Europe
    • 5.3.1 Europe Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020, (USD Million)
  • 5.4 Asia-Pacific
    • 5.4.1 Asia-Pacific Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020, (USD Million)
  • 5.5 Rest of the World (RoW)
    • 5.5.1 RoW Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020, (USD Million)

Chapter 6 Recommendations

  • 6.1 Market Strategy for Success
    • 6.1.1 Introduction of multi-usage and ready to use products
    • 6.1.2 Increasing emphasis on marketing campaigns
    • 6.1.3 Rigorous research and development initiatives

Chapter 7 Company Profiles

  • 7.1 Advanced Medical Solutions Group plc
    • 7.1.1 Company Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Product Portfolio
    • 7.1.4 Business Strategies
    • 7.1.5 Recent Developments
  • 7.2 Baxter
    • 7.2.1 Company Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Product Portfolio
    • 7.2.4 Business Strategies
    • 7.2.5 Recent Developments
  • 7.3 Cohera Medical, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Product Portfolio
    • 7.3.4 Business Strategies
    • 7.3.5 Recent Developments
  • 7.4 CryoLife, Inc.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Product Portfolio
    • 7.4.4 Business Strategies
    • 7.4.5 Recent Developments
  • 7.5 C.R. Bard, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Overview
    • 7.5.3 Product Portfolio
    • 7.5.4 Business Strategies
    • 7.5.5 Recent Developments
  • 7.6 Johnson & Johnson Services, Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Overview
    • 7.6.3 Product Portfolio
    • 7.6.4 Business Strategies
    • 7.6.5 Recent Developments
  • 7.7 Integra LifeSciences Corporation
    • 7.7.1 Company Overview
    • 7.7.2 Financial Overview
    • 7.7.3 Product Portfolio
    • 7.7.4 Business Strategies
    • 7.7.5 Recent Development
  • 7.8 Pfizer, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Overview
    • 7.8.3 Product Portfolio
    • 7.8.4 Business Strategies
    • 7.8.5 Recent Developments

List of Figures

  • FIG. 1 Global Hemostasis and Tissue Sealing Agents Market: Market Segmentation
  • FIG. 2 Global Hemostasis and Tissue Sealing Agents Market, by Types of Products, 2013 (USD Million)
  • FIG. 3 Comparative Analysis: Global Hemostasis and Tissue Sealing Agents Market, by Geography, 2013 and 2020 (Value %)
  • FIG. 4 Global Percentage Change in the World's Population by Age: 2010-2050
  • FIG. 5 Latin America Aging Population % Change Compared to the total Latin American Population Age: 2005 - 2050
  • FIG. 6 Porter's Five Forces Analysis: Global Hemostasis and Tissue Sealing Agents Market
  • FIG. 7 Market Attractiveness Analysis: Global Hemostasis and Tissue Sealing Agents Market, by Geography
  • FIG. 8 Global Hemostasis and Tissue Sealing Agents Market: Market Share, by Key Players, 2013 (%)
  • FIG. 9 Global Collagen-based Hemostats Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 10 Global ORC-based Topical Hemostats Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 11 Global Gelatin-based Hemostats Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 12 Global Polysaccharide-based Hemostats Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 13 Global Active Hemostats Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 14 Global Flowable Hemostats Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 15 Global Fibrin-based Tissue Sealant Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 16 Global Other Natural Tissue Sealant Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 17 Global Cyanoacrylate-based Tissue Sealant Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 18 Global Other Synthetic Tissue Sealant Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 19 Global Adhesion Barrier Products Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 20 North America Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 21 Europe Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 22 Asia-Pacific Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 23 RoW Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 24 Advanced Medical Solutions Group plc: Annual Revenues, 2011 - 2013 (USD Million)
  • FIG. 25 Baxter, Annual Revenue: 2011 - 2013 (USD Million)
  • FIG. 26 CryoLife, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 27 C. R. Bard, Inc., Annual Revenue: 2011 - 2013 (USD Million)
  • FIG. 28 Johnson & Johnson Services, Inc., Annual Revenue: 2011 - 2013 (USD Million)
  • FIG. 29 Integra LifeSciences Corporation, Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 30 Pfizer, Inc., Annual Revenue, 2011 - 2013 (USD Million)

List of Tables

  • TABLE 1 Market Snapshot: Global Hemostasis and Tissue Sealing Agents Market (2013 & 2020)
  • TABLE 2 Impact Analysis of Market Drivers
  • TABLE 3 Impact Analysis of Market Restraints
  • TABLE 4 Global Hemostasis and Tissue Sealing Agents Market Revenue, by Types of Products, 2012 - 2020 (USD Million)
  • TABLE 5 Global Topical Hemostats Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 6 Global Mechanical Hemostats Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 7 Global Adhesive and Tissue Sealing Agents Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 8 Global Natural Tissue Sealants Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 9 Global Synthetic Tissue Sealant Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 10 Global Hemostasis and Tissue Sealing Agents Market Revenue, by Geography, 2012 - 2020 (USD Million)
Back to Top